The groundbreaking immune therapy work being done by The Children’s of Hospital of Philadelphia’s Stephen M. Grupp, MD, PhD, was recently highlighted on Australia’s 60 Minutes.
Category Archive: Center for Childhood Cancer Research
Permanent link to this article: http://blog.research.chop.edu/groundbreaking-immune-therapy-featured-60-minutes-australia/
Apr 23 2013
Permanent link to this article: http://blog.research.chop.edu/genetic-study-suggests-fine-tuning-drugs-for-pediatric-brain-tumors/
Apr 10 2013
Permanent link to this article: http://blog.research.chop.edu/chop-leads-dream-team-as-stand-up-to-cancer-and-st-baldricks-take-aim-at-childrens-cancers/
Mar 26 2013
Permanent link to this article: http://blog.research.chop.edu/advanced-cell-therapy-eliminates-aggressive-leukemia-in-two-children/
Mar 07 2013
The innovative work being done by CHOP’s Stephen Grupp, MD, was recently featured on the CBS show The Doctors. Dr. Grupp, the Center for Childhood Cancer Research’s director of translational research, discussed his trial using immune therapy to treat an aggressive form of childhood leukemia, acute lymphoblastic leukemia (ALL). While roughly 85 percent of ALL …
Permanent link to this article: http://blog.research.chop.edu/chop-researchers-innovative-immune-therapy-featured-on-the-doctors/
Jan 24 2013
A recent genomic study of neuroblastoma reinforces the challenges of treating the most aggressive forms of this disease. Contrary to expectations, the researchers found relatively few recurrent gene mutations — mutations that would suggest new targets for neuroblastoma treatment. Instead, the investigators have refocused on how neuroblastoma tumors evolve in response to medicine and other factors.
Permanent link to this article: http://blog.research.chop.edu/study-shows-neuroblastoma-evolves-rapidly-limiting-treatment-targets/